HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yoichi Nakazato Selected Research
Yoichi Nakazato Research Topics
Disease
60
Neoplasms (Cancer)
01/2023 - 03/2002
20
Glioblastoma (Glioblastoma Multiforme)
01/2023 - 03/2002
17
Glioma (Gliomas)
12/2021 - 01/2002
9
Brain Neoplasms (Brain Tumor)
02/2016 - 03/2002
8
Astrocytoma (Pilocytic Astrocytoma)
10/2013 - 09/2002
7
Germinoma
04/2023 - 08/2015
5
Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
04/2023 - 08/2015
5
Alzheimer Disease (Alzheimer's Disease)
12/2011 - 10/2002
4
Oligodendroglioma
10/2013 - 11/2011
4
Multiple System Atrophy
12/2011 - 06/2002
3
Teratoma (Teratoid Tumor)
04/2023 - 04/2012
3
Meningioma (Meningiomas)
10/2013 - 08/2008
3
Neurodegenerative Diseases (Neurodegenerative Disease)
02/2013 - 09/2004
3
Neurilemmoma (Schwannoma)
07/2012 - 02/2003
3
Parkinson Disease (Parkinson's Disease)
12/2011 - 01/2009
3
Synucleinopathies
10/2010 - 09/2004
2
Disease Progression
12/2021 - 06/2011
2
Neuroepithelial Neoplasms (Gliomatosis Cerebri)
05/2019 - 10/2009
2
Erythema
10/2013 - 08/2011
2
Dyspnea (Shortness of Breath)
07/2013 - 11/2007
2
Neoplasm Metastasis (Metastasis)
04/2013 - 01/2010
2
Brain Diseases (Brain Disorder)
12/2012 - 09/2003
2
Ganglion Cysts (Ganglion)
10/2012 - 06/2003
2
Gliosarcoma
09/2012 - 05/2012
2
Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
12/2011 - 07/2006
2
Hemangioblastoma
12/2009 - 03/2002
2
Ependymoma
12/2009 - 09/2002
2
Typical Teratoid Rhabdoid Tumor
09/2009 - 07/2005
2
Residual Neoplasm
01/2009 - 05/2003
2
Tauopathies
06/2008 - 09/2004
2
Edema (Dropsy)
09/2006 - 02/2003
2
Carcinogenesis
12/2004 - 06/2003
2
Cytomegalovirus Infections (Inclusion Disease)
09/2004 - 06/2004
2
Frontotemporal Dementia (Semantic Dementia)
09/2004 - 01/2003
2
Gliosis
06/2004 - 06/2002
1
Testicular Neoplasms (Testicular Cancer)
01/2022
1
Rhabdoid Tumor (Rhabdoid Tumors)
02/2016
1
Choriocarcinoma
08/2015
1
Hemangiosarcoma (Angiosarcoma)
01/2015
Drug/Important Bio-Agent (IBA)
12
Glial Fibrillary Acidic Protein
IBA
01/2014 - 06/2002
11
Proteins (Proteins, Gene)
FDA Link
01/2016 - 09/2002
9
Vimentin
IBA
09/2009 - 05/2003
7
Antibodies
IBA
01/2015 - 06/2002
7
Synaptophysin
IBA
01/2014 - 06/2002
7
Nestin
IBA
07/2012 - 03/2002
5
alpha-internexin
IBA
10/2015 - 06/2004
5
Mucin-1 (CA 15-3 Antigen)
IBA
06/2013 - 05/2003
5
Keratins (Keratin)
IBA
07/2011 - 07/2005
5
S100 Proteins (S 100 Protein)
IBA
01/2010 - 02/2006
4
ErbB Receptors (EGF Receptor)
IBA
10/2013 - 01/2002
4
alpha-Synuclein
IBA
01/2009 - 06/2002
3
Tumor Biomarkers (Tumor Markers)
IBA
04/2023 - 12/2019
3
Cancer Vaccines
IBA
01/2023 - 08/2011
3
Formaldehyde (Formol)
FDA Link
01/2023 - 08/2011
3
Temozolomide (Temodar)
FDA Link
Generic
12/2021 - 01/2013
3
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
10/2013 - 04/2011
3
Nimustine
IBA
02/2013 - 01/2009
3
Complementary DNA (cDNA)
IBA
11/2012 - 09/2002
3
Ubiquitin
IBA
12/2011 - 06/2002
3
Neurofilament Proteins
IBA
09/2009 - 06/2002
2
Chorionic Gonadotropin (Human Chorionic Gonadotropin)
FDA Link
Generic
04/2023 - 08/2015
2
Paraffin
IBA
01/2023 - 05/2004
2
Antigens
IBA
01/2022 - 06/2003
2
Steroids
IBA
09/2021 - 06/2013
2
Messenger RNA (mRNA)
IBA
08/2015 - 07/2005
2
Biomarkers (Surrogate Marker)
IBA
10/2014 - 01/2012
2
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
01/2014 - 01/2013
2
Cisplatin (Platino)
FDA Link
Generic
04/2013 - 09/2006
2
Ifosfamide
FDA Link
Generic
04/2013 - 09/2006
2
Etoposide (VP 16)
FDA Link
Generic
04/2013 - 09/2006
2
Chromogranin A
IBA
04/2012 - 07/2005
2
Synucleins
IBA
06/2011 - 10/2010
2
Thallium-201
IBA
01/2010 - 12/2009
2
Glutamic Acid (Glutamate)
FDA Link
10/2007 - 07/2007
2
AMPA Receptors (AMPA Receptor)
IBA
07/2007 - 09/2002
2
alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
IBA
07/2007 - 09/2002
2
Glutamate Receptors (Glutamate Receptor)
IBA
07/2007 - 09/2002
2
Caspase 3 (Caspase-3)
IBA
06/2007 - 03/2005
2
DNA (Deoxyribonucleic Acid)
IBA
06/2007 - 01/2006
2
tissue-factor-pathway inhibitor 2 (PP5)
IBA
05/2006 - 06/2003
2
Tumor Protein p73
IBA
12/2004 - 09/2002
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
04/2023
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2023
1
Carboxylic Acids
IBA
12/2021
1
Nivolumab
IBA
12/2021
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
05/2019
1
Nuclear Proteins (Protein, Nuclear)
IBA
02/2016
1
choline transporter
IBA
01/2016
1
Protein Kinase C-alpha
IBA
01/2016
1
Cyclins
IBA
10/2015
1
Cyclin D1
IBA
10/2015
Therapy/Procedure
16
Radiotherapy
12/2021 - 05/2003
9
Drug Therapy (Chemotherapy)
04/2023 - 01/2007
9
Therapeutics
09/2021 - 01/2002
2
Chemoradiotherapy
01/2023 - 02/2013
2
Aftercare (After-Treatment)
12/2021 - 04/2011
2
Intravenous Injections
10/2013 - 11/2009
2
Craniotomy
06/2013 - 08/2008
2
Combination Drug Therapy (Combination Chemotherapy)
01/2010 - 09/2006
1
Ligation
05/2019